ArticleMikrochimica acta2025
Au@Ag@AgCl core-shell nanostructure-based label-free biosensor for sensitive colorimetric detection of urease.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
A label-free colorimetric biosensor based on Au@Ag@AgCl core-shell nanomaterials has been developed. The biosensor operated through a unique mechanism where Au@Ag@AgCl nanoparticles were progressively etched by ammonia produced during urease-catalyzed urea decomposition. This etching process induced a distinct color transition of the colloidal solution from orange to pink and ultimately to red, enabling quantitative determination of urease concentration. The multi-core-shell design of Au@Ag@AgCl provided highly enriched color gradients and significantly enhanced visual resolution, achieving a detection limit of 0.147 U/mL, which was 85 times lower than that of the commercial urease test strips. Notably, the assay required no complex surface modifications or separation procedures, offering high operational simplicity which could be accomplished within 15 min. All these advantages greatly facilitated in-situ and in-time detection of urease. Finally, this assay was applied to the detection of simulated saliva samples with recoveries ranging from 104.4% to 123.0%, thereby validating its robust anti-interference capability and potential application in practice. Thus, the proposed Au@Ag@AgCl core-shell nanostructure-based label-free biosensor might provide a rapid, quantitative, and user-friendly alternative approach for monitoring Heliobacter pylori infection.
Indexed as
Identifiers
41175148What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.